Known targets — ChEMBL curated mechanism
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
The experimentally established mechanism targets of Phosphoric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Phosphoric Acid SCHEMBL6310108 | 1.00 | SLC34A1 (0.73) | — | |
| Phosphoric Acid SCHEMBL28156368 | 0.95 | — | — | |
| Phosphoric Acid SCHEMBL11314977 | 0.95 | — | — | |
| Phosphoric Acid SCHEMBL28165886 | 0.95 | — | — | |
| Phosphoric Acid SCHEMBL5173653 | 0.95 | SLC34A1 (0.67) | — | |
| Phosphoric Acid SCHEMBL8710287 | 0.95 | SLC34A1 (0.67) | — | |
| Phosphoric Acid SCHEMBL532270 | 0.95 | SLC34A1 (0.82) | — | |
| Phosphoric Acid SCHEMBL2121856 | 0.95 | SLC34A1 (0.67) | — | |
| Phosphoric Acid SCHEMBL4332135 | 0.95 | SLC34A1 (0.82) | — | |
| Phosphoric Acid SCHEMBL5608739 | 0.95 | SLC34A1 (0.82) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1456 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025129096-A1 | CEMENTITIOUS MATERIALS AND ADDITIVES CONTAINING ALUMINUM AND/OR SILICEOUS MATERIALS AND METHODS OF MAKING THEREOF | SUBLIME SYSTEMS, INC. (US) | 2025-06-19 | — | — | WO | claimed |
| CN-120137430-A | Technology of pure inorganic multifunctional mineral paint | 四川裕霖环境工程有限公司 | 2025-06-13 | — | — | CN | claimed |
| CN-119969630-A | Electronic atomizing liquid and electronic atomizing device | 思摩尔国际控股有限公司 | 2025-05-13 | — | — | CN | claimed |
| CN-119768057-A | Moisture activated chlorine dioxide releasing powder and method of manufacture | 菲克斯科技公司 | 2025-04-04 | — | — | CN | claimed |
| CN-119751854-A | Method for improving crystallization capacity of semi-aromatic nylon and modified semi-aromatic nylon | 上海中化科技有限公司 | 2025-04-04 | — | — | CN | claimed |
| CN-222409470-U | Low-sodium potassium phosphate storage equipment | 四川西陇科学有限公司 | 2025-01-28 | — | — | CN | claimed |
| EP-4405417-A1 | ENCAPSULATION OF FLAME RETARDANT AGENTS BY ATOMIC LAYER DEPOSITION FOR IMPROVED FLAME RETARDANT FORMULATIONS | SHPP Global Technologies B.V. (NL) | 2024-07-31 | — | — | EP | claimed |
| CN-118176249-A | Encapsulation of flame retardants by atomic layer deposition to improve flame retardant formulations | 高新特殊工程塑料全球技术有限公司 | 2024-06-11 | — | — | CN | claimed |
| US-11945909-B2 | Process for preparing polycarbonates using a catalyst system having a quarternary nitrogen compond and a quarternary phosphorous compound | EPC Engineering & Technologies GmbH (DE) | 2024-04-02 | — | — | US | claimed |
| WO-2024030639-A1 | MOISTURE-ACTIVATED CHLORINE DIOXIDE-RELEASING POWDER AND METHOD OF MANUFACTURE | Phiex Technologies, Inc. (US) | 2024-02-08 | — | — | WO | claimed |
| EP-0074169-B1 | MICRO-BIOLOGICAL PRODUCTION OF MUCONIC ACID | CELANESE CORPORATION (US) | 1987-01-14 | — | — | EP | claimed |
| US-4610815-A | Process for producing and obtaining anaphylatoxin- and cocytotaxin-containing leucotaxine preparations and of anaphylatoxin and cocytotaxin proteins in molecularly homogeneous, biologically active form | MAX-PLANCK GESELLSCHAFT ZUR FORDERUNG DER WISSENSCHAFTEN (DE) | 1986-09-09 | — | — | US | claimed |
| US-4495096-A | Process for producing and obtaining anaphylatoxin-and cocytotaxin-containing leucotaxine preparations and of anaphylatoxin and cocytotaxin proteins in molecularly homogeneous, biologically active form | MAX-PLANCK GESELLSCHAFT ZUR FORDERUNG DER WISSENCHAFTEN (DE) | 1985-01-22 | — | — | US | claimed |
| EP-0042560-B1 | A PROCESS FOR PRODUCING AND OBTAINING ANAPHYLATOXIN- AND COCYTOTAXIN-CONTAINING LEUCOTAXINE PREPARATIONS AND OF ANAPHYLATOXIN AND COCYTOTAXIN PROTEINS IN MOLECULARLY HOMOGENEOUS, BIOLOGICALLY ACTIVE FORM | Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. (DE) | 1984-10-17 | — | — | EP | claimed |
| US-4452735-A | RECRUITMENT FROM BONE MARROW INTO BLOOD, PROTEOLYSIS, SEPARATION | MAX-PLANCK GESELLSCHAFT ZUR FORDERUNG DER WISSENSCHAFTEN (DE) | 1984-06-05 | — | — | US | claimed |
| EP-0047979-B1 | SERUM-DERIVED \"LEUKORECRUITIN\": A PROTEIN MEDIATOR OF INFLAMMATION FROM MAMMALIAN SERUM FOR SPECIFIC INDUCTION OF A LEUKOCYTOSIS REACTION, A PROCESS FOR ITS BIOTECHNICAL PRODUCTION AND ISOLATION IN MOLECULARLY HOMOGENOUS, CRYSTALLIZABLE, BIOLOGICALLY SPECIFIC, ACTIVE FORM, AND LEUKORECRUITIN-CONTAINING PHARMACEUTICAL COMPOSITIONS | Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. (DE) | 1983-12-07 | — | — | EP | claimed |
| EP-0074169-A1 | Micro-biological production of muconic acid | CELANESE CORPORATION (US) | 1983-03-16 | — | — | EP | claimed |
| US-4355107-A | Production of muconic acid | CELANESE CORPORATION (US) | 1982-10-19 | — | — | US | claimed |
| EP-0047979-A1 | Serum-derived \"Leukorecruitin\": a protein mediator of inflammation from mammalian serum for specific induction of a leukocytosis reaction, a process for its biotechnical production and isolation in molecularly homogenous, crystallizable, biologically specific, active form, and leukorecruitin-containing pharmaceutical compositions | Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. (DE) | 1982-03-24 | — | — | EP | claimed |
| EP-0042560-A2 | A process for producing and obtaining anaphylatoxin- and cocytotaxin-containing leucotaxine preparations and of anaphylatoxin and cocytotaxin proteins in molecularly homogeneous, biologically active form | Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. (DE) | 1981-12-30 | — | — | EP | claimed |